NCT00950768View on ClinicalTrials.gov

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Multiple MyelomaDiagnosis
Interventions
PROCEDURE

Autologous transplantation

Tandem autologous transplantation Melphalan 100 mg/m2 versus Melphalan 200 mg/m2

All Listed Sponsors
lead

Azienda Ospedaliera San Giovanni Battista

OTHER

NCT00950768 - Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients | Biotech Hunter | Biotech Hunter